Frontlight ResearchEarly access
Thalassaemia trials in South Korea
1 of 1 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
- Where
- Seoul
- Age
- 19 years and over
- People
- 104
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06073860